Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Salk

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|June 26, 1981
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell linesG Yogeeswaran, P L Salk
Progress in Clinical and Biological Research|January 1, 1982
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylationS Karpatkin, E Pearlstein, P L Salk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell lineE Pearlstein, P L Salk, G Yogeeswaran, et al.
Immunology Today|May 1, 1993
Can AIDS be prevented by T-cell vaccination?H Atlan, M J Gersten, P L Salk, et al.
Research in Immunology|March 1, 1994
Mechanisms of autoimmunity and AIDS: prospects for therapeutic interventionH Atlan, M J Gersten, P L Salk, et al.
Developments in Biological Standardization|January 1, 1981
Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologicsJ C Petricciani, P L Salk, J Salk, et al.
Developments in Biological Standardization|January 1, 1981
Detection and elimination of cellular nucleic acids in biologicals produced on continuous cell linesA L van Wezel, P van der Marel, C P van Beveren, et al.
Vaccine|September 1, 1994
Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection?B Vaslin, R Le Grand, G Vogt, et al.
Vaccine|May 1, 1998
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccinationP Lanza, R B Moss, W Giermakowska, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-upA M Levine, S Groshen, J Allen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|June 26, 1981
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell linesG Yogeeswaran, P L Salk
Progress in Clinical and Biological Research|January 1, 1982
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylationS Karpatkin, E Pearlstein, P L Salk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell lineE Pearlstein, P L Salk, G Yogeeswaran, et al.
Immunology Today|May 1, 1993
Can AIDS be prevented by T-cell vaccination?H Atlan, M J Gersten, P L Salk, et al.
Research in Immunology|March 1, 1994
Mechanisms of autoimmunity and AIDS: prospects for therapeutic interventionH Atlan, M J Gersten, P L Salk, et al.
Developments in Biological Standardization|January 1, 1981
Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologicsJ C Petricciani, P L Salk, J Salk, et al.
Developments in Biological Standardization|January 1, 1981
Detection and elimination of cellular nucleic acids in biologicals produced on continuous cell linesA L van Wezel, P van der Marel, C P van Beveren, et al.
Vaccine|September 1, 1994
Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection?B Vaslin, R Le Grand, G Vogt, et al.
Vaccine|May 1, 1998
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccinationP Lanza, R B Moss, W Giermakowska, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-upA M Levine, S Groshen, J Allen, et al.
Pageof 1